These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

562 related articles for article (PubMed ID: 21710489)

  • 1. Mesenchymal stem cell inhibition of T-helper 17 cell- differentiation is triggered by cell-cell contact and mediated by prostaglandin E2 via the EP4 receptor.
    Duffy MM; Pindjakova J; Hanley SA; McCarthy C; Weidhofer GA; Sweeney EM; English K; Shaw G; Murphy JM; Barry FP; Mahon BP; Belton O; Ceredig R; Griffin MD
    Eur J Immunol; 2011 Oct; 41(10):2840-51. PubMed ID: 21710489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fetal BM-derived mesenchymal stem cells promote the expansion of human Th17 cells, but inhibit the production of Th1 cells.
    Guo Z; Zheng C; Chen Z; Gu D; Du W; Ge J; Han Z; Yang R
    Eur J Immunol; 2009 Oct; 39(10):2840-9. PubMed ID: 19637224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated T-cells and pro-inflammatory cytokines differentially regulate prostaglandin E2 secretion by mesenchymal stem cells.
    Hegyi B; Kudlik G; Monostori E; Uher F
    Biochem Biophys Res Commun; 2012 Mar; 419(2):215-20. PubMed ID: 22333568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1α,25-Dihydroxyvitamin D3 and all-trans retinoic acid synergistically inhibit the differentiation and expansion of Th17 cells.
    Ikeda U; Wakita D; Ohkuri T; Chamoto K; Kitamura H; Iwakura Y; Nishimura T
    Immunol Lett; 2010 Nov; 134(1):7-16. PubMed ID: 20655952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opposing effect of mesenchymal stem cells on Th1 and Th17 cell polarization according to the state of CD4+ T cell activation.
    Carrión F; Nova E; Luz P; Apablaza F; Figueroa F
    Immunol Lett; 2011 Mar; 135(1-2):10-6. PubMed ID: 20888363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invariant NKT cells regulate experimental autoimmune uveitis through inhibition of Th17 differentiation.
    Oh K; Byoun OJ; Ham DI; Kim YS; Lee DS
    Eur J Immunol; 2011 Feb; 41(2):392-402. PubMed ID: 21268009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin E₂ down-regulates the expression of CD25 on bovine T cells, and this effect is mediated through the EP4 receptor.
    Maślanka T; Spodniewska A; Barski D; Jasiecka A; Zuśka-Prot M; Ziółkowski H; Markiewicz W; Jaroszewski JJ
    Vet Immunol Immunopathol; 2014 Aug; 160(3-4):192-200. PubMed ID: 25001909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandin E2 enhances Th17 responses via modulation of IL-17 and IFN-gamma production by memory CD4+ T cells.
    Napolitani G; Acosta-Rodriguez EV; Lanzavecchia A; Sallusto F
    Eur J Immunol; 2009 May; 39(5):1301-12. PubMed ID: 19384872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simvastatin inhibits IFN regulatory factor 4 expression and Th17 cell differentiation in CD4+ T cells derived from patients with multiple sclerosis.
    Zhang X; Tao Y; Troiani L; Markovic-Plese S
    J Immunol; 2011 Sep; 187(6):3431-7. PubMed ID: 21856936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype.
    Ghannam S; Pène J; Moquet-Torcy G; Jorgensen C; Yssel H
    J Immunol; 2010 Jul; 185(1):302-12. PubMed ID: 20511548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin E2 plays a key role in the immunosuppressive properties of adipose and bone marrow tissue-derived mesenchymal stromal cells.
    Yañez R; Oviedo A; Aldea M; Bueren JA; Lamana ML
    Exp Cell Res; 2010 Nov; 316(19):3109-23. PubMed ID: 20804749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor cyclooxygenase-2/prostaglandin E2-dependent promotion of FOXP3 expression and CD4+ CD25+ T regulatory cell activities in lung cancer.
    Sharma S; Yang SC; Zhu L; Reckamp K; Gardner B; Baratelli F; Huang M; Batra RK; Dubinett SM
    Cancer Res; 2005 Jun; 65(12):5211-20. PubMed ID: 15958566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism.
    Djouad F; Charbonnier LM; Bouffi C; Louis-Plence P; Bony C; Apparailly F; Cantos C; Jorgensen C; Noël D
    Stem Cells; 2007 Aug; 25(8):2025-32. PubMed ID: 17510220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synovial fibroblasts directly induce Th17 pathogenicity via the cyclooxygenase/prostaglandin E2 pathway, independent of IL-23.
    Paulissen SM; van Hamburg JP; Davelaar N; Asmawidjaja PS; Hazes JM; Lubberts E
    J Immunol; 2013 Aug; 191(3):1364-72. PubMed ID: 23817417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis.
    Zheng ZH; Li XY; Ding J; Jia JF; Zhu P
    Rheumatology (Oxford); 2008 Jan; 47(1):22-30. PubMed ID: 18077486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic transplantation of allogenic fetal membrane-derived mesenchymal stem cells suppresses Th1 and Th17 T cell responses in experimental autoimmune myocarditis.
    Ohshima M; Yamahara K; Ishikane S; Harada K; Tsuda H; Otani K; Taguchi A; Miyazato M; Katsuragi S; Yoshimatsu J; Kodama M; Kangawa K; Ikeda T
    J Mol Cell Cardiol; 2012 Sep; 53(3):420-8. PubMed ID: 22796574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phagocytosis of apoptotic cells modulates mesenchymal stem cells osteogenic differentiation to enhance IL-17 and RANKL expression on CD4+ T cells.
    Tso GH; Law HK; Tu W; Chan GC; Lau YL
    Stem Cells; 2010 May; 28(5):939-54. PubMed ID: 20222014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-23 promotes Th17 differentiation by inhibiting T-bet and FoxP3 and is required for elevation of interleukin-22, but not interleukin-21, in autoimmune experimental arthritis.
    Mus AM; Cornelissen F; Asmawidjaja PS; van Hamburg JP; Boon L; Hendriks RW; Lubberts E
    Arthritis Rheum; 2010 Apr; 62(4):1043-50. PubMed ID: 20131264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell-intrinsic prostaglandin E
    Lee J; Aoki T; Thumkeo D; Siriwach R; Yao C; Narumiya S
    J Allergy Clin Immunol; 2019 Feb; 143(2):631-643. PubMed ID: 29935220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-23-dependent and -independent enhancement pathways of IL-17A production by lactic acid.
    Yabu M; Shime H; Hara H; Saito T; Matsumoto M; Seya T; Akazawa T; Inoue N
    Int Immunol; 2011 Jan; 23(1):29-41. PubMed ID: 21131367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.